EPM speaks to technology company Lifebit about its collaboration with pharmaceutical organisation Boehringer to report on infectious disease outbreaks.
In June this year pharmaceutical company Boehringer announced a collaboration with Lifebit, a technology company specialising in the collection and analysis of big data within life sciences, with an aim of helping companies discover new drugs and improve patient outcomes.
The partnership will see both companies working together to detect and report on global disease outbreaks. Lifebit is to use its REAL platform, which uses advanced analytic capabilities to automatically notify users of relevant outbreaks, such as transboundary disease spread or the emergence of pathogens, such as Covid-19.